Nothing Special   »   [go: up one dir, main page]

ATE203023T1 - Tropanderivate, deren herstellung und verwendung - Google Patents

Tropanderivate, deren herstellung und verwendung

Info

Publication number
ATE203023T1
ATE203023T1 AT97903355T AT97903355T ATE203023T1 AT E203023 T1 ATE203023 T1 AT E203023T1 AT 97903355 T AT97903355 T AT 97903355T AT 97903355 T AT97903355 T AT 97903355T AT E203023 T1 ATE203023 T1 AT E203023T1
Authority
AT
Austria
Prior art keywords
derivatives
disorders
tropande
production
monoamine neurotransmitter
Prior art date
Application number
AT97903355T
Other languages
English (en)
Inventor
Joergen Scheel-Krueger
Peter Moldt
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE203023T1 publication Critical patent/ATE203023T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97903355T 1996-02-22 1997-02-21 Tropanderivate, deren herstellung und verwendung ATE203023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK19496 1996-02-22
PCT/EP1997/000850 WO1997030997A1 (en) 1996-02-22 1997-02-21 Tropane-derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE203023T1 true ATE203023T1 (de) 2001-07-15

Family

ID=8090830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903355T ATE203023T1 (de) 1996-02-22 1997-02-21 Tropanderivate, deren herstellung und verwendung

Country Status (32)

Country Link
US (3) US6288079B1 (de)
EP (2) EP0885220B1 (de)
JP (1) JP3238414B2 (de)
KR (1) KR100446571B1 (de)
CN (1) CN1077574C (de)
AT (1) ATE203023T1 (de)
AU (1) AU720358B2 (de)
BG (1) BG63945B1 (de)
BR (1) BR9707636A (de)
CA (1) CA2244773C (de)
CZ (1) CZ287007B6 (de)
DE (1) DE69705608T2 (de)
DK (1) DK0885220T3 (de)
EE (1) EE04751B1 (de)
ES (1) ES2159839T3 (de)
GR (1) GR3036829T3 (de)
HK (1) HK1018957A1 (de)
HU (1) HU228356B1 (de)
IL (1) IL125146A (de)
IS (1) IS1824B (de)
NO (1) NO318731B1 (de)
NZ (1) NZ330886A (de)
PL (1) PL185132B1 (de)
PT (1) PT885220E (de)
RU (1) RU2167876C2 (de)
SG (1) SG99853A1 (de)
SI (1) SI0885220T1 (de)
SK (1) SK281813B6 (de)
TR (1) TR199801641T2 (de)
UA (1) UA49872C2 (de)
WO (1) WO1997030997A1 (de)
ZA (1) ZA971525B (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69943110D1 (de) * 1998-09-30 2011-02-17 Nihon Mediphysics Co Ltd Verfahren zur herstellung von optisch aktiven tropinon-monokarbonsäurederivaten
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
JP2005508872A (ja) * 2001-05-23 2005-04-07 ニューロサーチ、アクティーゼルスカブ トロパン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害剤として使用する方法
GB2380733A (en) * 2001-10-11 2003-04-16 Bertha Kalifon Madras Non-amine tropane analogues
WO2003037313A2 (en) * 2001-10-31 2003-05-08 Recovery Pharmaceuticals, Inc. Methods for the treatment of addiction
WO2003045388A1 (en) * 2001-11-30 2003-06-05 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
MXPA04011859A (es) 2002-05-30 2005-03-31 Neurosearch As Inhibidores de la receptacion de monoamina triple para el tratamiento de dolor cronico.
AU2003277827A1 (en) 2002-11-01 2004-05-25 Neurosearch A/S Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP2386566A3 (de) 2002-12-02 2012-02-15 Xenome Ltd Chi-Conotoxin-Peptide (II)
ES2383358T3 (es) 2002-12-02 2012-06-20 Xenome Ltd Péptidos de chi-conotoxina que tienen un ácido piroglutámico N-terminal
CN100551924C (zh) * 2003-02-12 2009-10-21 神经研究公司 8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
CN100372850C (zh) * 2003-02-12 2008-03-05 神经研究公司 新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
AU2004212165B2 (en) 2003-02-12 2010-02-18 Neurosearch A/S Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2515584A1 (en) 2003-02-12 2004-08-26 Neurosearch A/S 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
AU2004249441B2 (en) 2003-06-24 2009-11-12 Neurosearch A/S Novel 8-aza-bicyclo(3.2.1)octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
AR045141A1 (es) * 2003-07-31 2005-10-19 Neurosearch As Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas.
EP1682545B1 (de) 2003-10-03 2007-12-12 Pfizer Limited Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
ATE519486T1 (de) 2003-10-16 2011-08-15 Neurosearch As Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem acetylcholinesterase-hemmer
JP2007511559A (ja) * 2003-11-18 2007-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 固形医薬製剤
EP1708707A1 (de) * 2004-01-22 2006-10-11 Neurosearch A/S Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem n-methyl-d-aspartat (nmda)-rezeptorantagonisten
CA2554616A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
NZ547919A (en) * 2004-01-22 2009-12-24 Neurosearch As Compounds for the sustained reduction of body weight
DE102004004965B4 (de) 2004-01-31 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates
WO2005117874A1 (en) * 2004-06-04 2005-12-15 Neurosearch A/S MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITOR FOR THE INHIBITION OF BETA-AMYLOID (Aß40 AND Aß42) -GENERATION
JP2008502650A (ja) * 2004-06-18 2008-01-31 ノイロサーチ アクティーゼルスカブ 新規な9−アザ−ビシクロ[3.3.1]ノナン誘導体及びこれらのモノアミン神経伝達物質再取り込み阻害剤としての使用
JP2008502651A (ja) 2004-06-18 2008-01-31 ノイロサーチ アクティーゼルスカブ モノアミン神経伝達物質再取込み阻害剤としての、新規アルキル置換ピペリジン誘導体及びその使用
US7524958B2 (en) 2004-06-18 2009-04-28 Neurosearch A/S Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
KR20070061846A (ko) 2004-09-30 2007-06-14 뉴로서치 에이/에스 신규한 크로멘-2-온 유도체 및 모노아민 신경전달물질재흡수 억제제로서의 이의 용도
EP2284170A1 (de) 2004-09-30 2011-02-16 NeuroSearch AS Neue chromen-2-one Derivate und ihre Verwendung als Monoamineneurotransmitter-Wiederaufnahmeinhibitoren
US7923444B2 (en) 2005-02-10 2011-04-12 Neurosearch A/S Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1869050A1 (de) * 2005-04-04 2007-12-26 Neurosearch A/S Neue substituierte diazabicycloderivate und ihre verwendung als inhibitoren der monoaminneurotransmitterwiederaufnahme
JP2008534653A (ja) 2005-04-08 2008-08-28 ノイロサーチ アクティーゼルスカブ 新規エナンチオマー及びモノアミン神経伝達物質再取り込み阻害剤としてのそれらの使用
WO2007000463A1 (en) * 2005-06-28 2007-01-04 Neurosearch A/S Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1899301B1 (de) * 2005-06-28 2010-09-15 NeuroSearch A/S Neue 3-aza-spiro[5.5]undec-8-en derivate und deren verwendung als inhibitoren der wiederaufnahme von monoaminneurotransmittern
ATE481386T1 (de) * 2005-06-28 2010-10-15 Neurosearch As Neue 3-aza-spiroä5.5üundec-8-en derivate und deren verwendung als inhibitoren der wiederaufnahme von monoaminneurotransmittern
JP2008546828A (ja) 2005-06-28 2008-12-25 ノイロサーチ アクティーゼルスカブ 新規な3−アザ−スピロ[5.5]ウンデカン誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのこれらの使用
EP1940404A2 (de) * 2005-07-12 2008-07-09 Boehringer Ingelheim International GmbH Pharmazeutische zusammensetzung mit 2,3-disubstituierten tropanen zur behandlung von störungen der libido
CN101495184A (zh) 2005-07-15 2009-07-29 Amr科技公司 芳基和杂芳基取代的四氢苯并氮杂及其在阻断去甲肾上腺素多巴胺和血清素的重摄取中的应用
WO2007025055A2 (en) 2005-08-24 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Benztropine compounds and uses thereof as dopamine uptake inhibitors
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
EP1779851A1 (de) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Behandlung von Diabetes
TW200804367A (en) * 2005-11-11 2008-01-16 Neurosearch As Novel compounds
CN101379063A (zh) 2006-02-10 2009-03-04 神经研究公司 3,9-二氮杂双环[3.3.1]壬烷衍生物及其作为单胺神经递质再摄取抑制剂的用途
TW200800980A (en) * 2006-02-17 2008-01-01 Neurosearch As Novel compounds
WO2008028903A2 (en) 2006-09-04 2008-03-13 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
MX2009002625A (es) * 2006-09-11 2009-03-24 Glaxo Group Ltd Compuestos azabiciclicos como inhibidores de la recaptacion de monoaminas.
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
TW200904815A (en) 2007-05-09 2009-02-01 Neurosearch As Novel compounds
US20100286195A1 (en) * 2007-09-10 2010-11-11 Neurosearch A/S Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2009034043A1 (en) * 2007-09-10 2009-03-19 Neurosearch A/S Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20110118304A1 (en) * 2007-11-20 2011-05-19 Neurosearch A/S Method for treating over-eating disorders
EP2222303A1 (de) * 2007-11-20 2010-09-01 NeuroSearch A/S Verfahren zur behandlung von sucht
PE20120373A1 (es) 2009-05-12 2012-05-17 Albany Molecular Res Inc 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina
WO2010132487A1 (en) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
MX2011011904A (es) 2009-05-15 2011-12-08 Neurosearch As Derivados de cromen-2-ona y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina.
WO2011032903A1 (en) 2009-09-21 2011-03-24 Neurosearch A/S Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20130040985A1 (en) 2010-01-29 2013-02-14 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 (en) 2010-03-25 2011-09-29 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US8153653B2 (en) * 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
WO2012000881A1 (en) 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP2606049A4 (de) 2010-08-17 2014-01-08 Albany Molecular Res Inc 2,5-methan- und 2,5-ethan-tetrahydrobenzazepin-derivate und ihre verwendung zur hemmung der wiederaufnahme von norepinephrin, dopamin und serotonin
JP5873487B2 (ja) 2010-10-07 2016-03-01 武田薬品工業株式会社 1,4−オキサゼパン誘導体
JP6203760B2 (ja) 2012-02-16 2017-09-27 サニオナ・エー/エス 併用療法のための医薬組成物
PL3265126T3 (pl) 2015-03-03 2021-12-06 Saniona A/S Preparaty połączenia tesofensyny i metoprololu
EA026727B1 (ru) * 2015-09-10 2017-05-31 Замертон Холдингс Лимитед Соль (1r,2r,3s)-3-(3,4-дихлорфенил)-2-(этоксиметил)-8-метил-8-азабицикло[3.2.1]октана и фталевой кислоты, способ её получения, продукт способа, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способы лечения и/или профилактики нарушений, связанных с ожирением
WO2017121432A1 (en) 2016-01-15 2017-07-20 Saniona A/S Tesofensine and metoprolol for treatment of hypertension
EA028995B1 (ru) * 2016-02-25 2018-01-31 Замертон Холдингс Лимитед Соль тезофензина и оптически активных ацетиламинокислот, их применение для лечения и/или профилактики нарушений, связанных с ожирением
CA3032349A1 (en) 2016-09-07 2018-03-15 Saniona A/S Tesofensine compositions
DE102017210141A1 (de) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Portion zur Bereitstellung tensidhaltiger Flotten
MX2021008208A (es) 2019-01-07 2021-11-17 Saniona As Tesofensina para la reduccion del peso corporal para pacientes con sindrome de prader-willi.
CA3176183A1 (en) 2020-04-22 2021-10-28 Jorgen Drejer Treatment of hypothalamic obesity
TWI772928B (zh) * 2020-10-21 2022-08-01 行政院原子能委員會核能研究所 非放射性標準品β-CFT之製備方法
TW202409027A (zh) 2022-07-08 2024-03-01 丹麥商創始人製藥股份有限公司 用於女性性功能障礙的治療之化合物
CN115572289A (zh) * 2022-10-24 2023-01-06 龙曦宁(上海)医药科技有限公司 一种特索芬辛的合成方法
WO2024089247A1 (en) 2022-10-28 2024-05-02 Initiator Pharma A/S Compound for treatment of pain
WO2024146892A1 (en) 2023-01-03 2024-07-11 Initiator Pharma A/S Compound for treatment of erectile dysfunction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281130A (en) 1979-05-24 1981-07-28 Sterling Drug Inc. Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate
US5496953A (en) 1990-08-09 1996-03-05 Research Triangle Institute Cocaine receptor binding ligands
US5128118A (en) 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
US5380848A (en) * 1990-08-09 1995-01-10 Research Triangle Institute Cocaine receptor binding ligands
KR100251339B1 (ko) * 1991-11-15 2000-09-01 제임스 씨. 하이트 코카인 수용체 결합 리간드
AU672644B2 (en) 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
DK0756596T3 (da) * 1994-04-19 2002-12-23 Neurosearch As Tropan-2-aldoximderivater som neurotransmitter-genoptagelsesinhibitorer
GB9626611D0 (en) * 1996-12-20 1997-02-05 Unilever Plc Agglomerated silicas

Also Published As

Publication number Publication date
BR9707636A (pt) 1999-07-27
GR3036829T3 (en) 2002-01-31
CA2244773A1 (en) 1997-08-28
IL125146A0 (en) 1999-01-26
CN1077574C (zh) 2002-01-09
CZ287007B6 (en) 2000-08-16
EP1130020A1 (de) 2001-09-05
SG99853A1 (en) 2003-11-27
EE9800254A (et) 1999-02-15
TR199801641T2 (xx) 1998-11-23
PL185132B1 (pl) 2003-02-28
SI0885220T1 (en) 2001-12-31
WO1997030997A1 (en) 1997-08-28
US6395748B2 (en) 2002-05-28
US6288079B1 (en) 2001-09-11
PL328503A1 (en) 1999-02-01
CZ252098A3 (cs) 1998-11-11
DK0885220T3 (da) 2001-10-15
US20010018444A1 (en) 2001-08-30
NO318731B1 (no) 2005-05-02
BG102637A (en) 1999-06-30
JP3238414B2 (ja) 2001-12-17
RU2167876C2 (ru) 2001-05-27
IL125146A (en) 2002-03-10
KR19990087127A (ko) 1999-12-15
JP2000504739A (ja) 2000-04-18
EP0885220B1 (de) 2001-07-11
CA2244773C (en) 2006-01-03
AU720358B2 (en) 2000-06-01
DE69705608D1 (de) 2001-08-16
SK281813B6 (sk) 2001-08-06
NZ330886A (en) 1999-02-25
HUP9901199A2 (hu) 1999-08-30
AU1794097A (en) 1997-09-10
NO983877D0 (no) 1998-08-21
BG63945B1 (bg) 2003-07-31
US20020128284A1 (en) 2002-09-12
ES2159839T3 (es) 2001-10-16
NO983877L (no) 1998-08-21
HK1018957A1 (en) 2000-01-14
EP0885220A1 (de) 1998-12-23
DE69705608T2 (de) 2002-05-16
IS4825A (is) 1998-08-17
ZA971525B (en) 1997-10-21
IS1824B (is) 2002-10-01
UA49872C2 (uk) 2002-10-15
HU228356B1 (en) 2013-03-28
KR100446571B1 (ko) 2004-11-03
CN1211982A (zh) 1999-03-24
SK92998A3 (en) 1998-11-04
PT885220E (pt) 2001-11-30
HUP9901199A3 (en) 2001-02-28
EE04751B1 (et) 2006-12-15

Similar Documents

Publication Publication Date Title
DE69705608D1 (de) Tropanderivate, deren herstellung und verwendung
WO1999037623A3 (en) Sulphonamide derivatives for treatment of cns disorders
UA105629C2 (uk) Похідні арилсульфоніл піразолін карбоксамідину як антагоністи 5-нт6
MX2009003183A (es) Derivados de sulfonilpirazolincarboxamidina como antagonistas de 5-ht6.
IS2164B (is) ß2-adrenvirk viðtaka gerandefni
WO2007028083A3 (en) 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
MX2009005509A (es) 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a).
NO20092688L (no) Forbindelser med en kombinasjon av cannabinoid-CB1 antagonisme og acetylcholinesteraseinhibering
MX2010009643A (es) Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a).
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
NZ592563A (en) 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
DE602006015193D1 (de) 8-alk0xy-4-methyl-3, 4-dihydr0-chinaz0lin-2-yl-amine und ihre verwendung als 5-ht5a-rezeptor-liganden
MX2010008239A (es) 2-aminoquinolinas.
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
UA98122C2 (ru) Производные сульфонилпиразол и сульфонилпиразолон карбоксамидина как антагонисты рецепторов 5-ht6
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
WO2000071533A3 (en) 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification